Author:
Salimi-Moosavi Hossein,Lee Jean,DeSilva Binodh,Doellgast George
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference25 articles.
1. FcRn: the neonatal Fc receptor comes of age;Roopenian;Nat. Rev. Immunol.,2007
2. Dose-dependent increases in circulating TGF-α and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independent;Mutsaers;Clin. Cancer Res.,2009
3. Antibody pharmacokinetics and pharmacodynamics;Lobo;J. Pharm. Sci.,2004
4. S. Tannebaum, A. Gautier, P. Lowe, A mechanism based binding model for the population pharmacokinetics and pharmacodynamics of canakinumab, a monoclonal antibody in development for rheumatoid arthritis, 2008 AAPS Annual Meeting. Atlanta, GA, www.aapsj.org/abstracts/AM_2008/AAPS2008-002581.PDF.
5. A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab;Hayashi;Br. J. Clin. Pharmacol.,2006
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献